Table 1 Age-specific results of primary HPV screening with the HC2 test and cytology triage test among eligible women who attended HPV screening trial in years 2003–2005

From: Type- and age-specific distribution of human papillomavirus in women attending cervical cancer screening in Finland

 

HPV screening

Cytology triage a

 

Total

Negative

Positive

Normal

ASC-US b

LSIL+ c

Age group ( y)

n

n

%

n

%

n

% of HC2+

n

% of HC2+

n

% of HC2+

25

1 724

1 307

75.8

417

24.2

258

61.7

97

23.2

62

14.8

30

3 724

3 174

85.2

550

14.8

321

58.3

132

24.0

97

17.6

35

3 900

3 531

90.5

369

9.5

194

52.3

99

26.7

76

20.5

40

4 649

4 347

93.5

302

6.5

167

55.1

74

24.4

61

20.1

45

4 335

4 112

94.9

223

5.1

145

64.7

52

23.2

26

11.6

50

4 575

4 342

94.9

233

5.1

154

65.8

58

24.8

21

9.0

55

4 885

4 629

94.8

256

5.2

182

70.8

46

17.9

28

10.9

60

3 988

3 798

95.2

190

4.8

139

72.0

28

14.5

23

11.9

65

1 215

1 181

97.2

34

2.8

22

64.7

8

23.5

4

11.8

Total

32 995

30 421

92.3

2574

7.8

1582

61.5

594

23.1

398

15.5

  1. Abbreviations: HC2=Hybrid Capture 2; HC2+=positive result in the HC2 test.
  2. aCytology triage missing or smear unsatisfactory for seven women who were included and cytology result was assumed to be normal.
  3. bPapanicolaou class II.
  4. cPapanicolaou class III-V, small proportion of II.
Back to article page